These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25864024)

  • 21. TQuest, A Web-Based Platform to Enable Precision Medicine by Linking a Tumor's Genetic Defects to Therapeutic Options.
    Gershkovich P; Platt J; Knopf J; Tasoulis MK; Shi W; Pusztai L; Hatzis C
    JCO Clin Cancer Inform; 2018 Dec; 2():1-13. PubMed ID: 30652574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized medicine: the medicine of tomorrow. Foreword.
    Tremblay-Servier M
    Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
    [No Abstract]   [Full Text] [Related]  

  • 23. Proteomic advances hold promise for precision medicine.
    Smith AD
    Am J Manag Care; 2014 Mar; 20(5 Spec No.):E14. PubMed ID: 25618628
    [No Abstract]   [Full Text] [Related]  

  • 24. Adult cancer clinical trials that fail to complete: an epidemic?
    Stensland KD; McBride RB; Latif A; Wisnivesky J; Hendricks R; Roper N; Boffetta P; Hall SJ; Oh WK; Galsky MD
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25190726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision medicine for nurses: 101.
    Lemoine C
    Semin Oncol Nurs; 2014 May; 30(2):84-99. PubMed ID: 24794082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
    Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
    J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation of a formalized precision medicine program in gynecologic oncology.
    Gunderson CC; Rowland MR; Wright DL; Andrade KL; Mannel RS; McMeekin DS; Moore KN
    Gynecol Oncol; 2016 Apr; 141(1):24-8. PubMed ID: 27016225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
    Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
    Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in clinical trials reports in common cancers between 1989 and 2000.
    Hillner BE
    J Clin Oncol; 2003 May; 21(9):1850-8. PubMed ID: 12721263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial experience with genomic profiling of heavily pretreated breast cancers.
    Staren ED; Braun D; Tan B; Gupta D; Kim S; Kramer K; Markman M
    Ann Surg Oncol; 2014 Oct; 21(10):3216-22. PubMed ID: 25047475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on research activity in the USA on Cancer Precision Medicine.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2016 Feb; 46(2):106-10. PubMed ID: 26531706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.
    Rodon J; Soria JC; Berger R; Batist G; Tsimberidou A; Bresson C; Lee JJ; Rubin E; Onn A; Schilsky RL; Miller WH; Eggermont AM; Mendelsohn J; Lazar V; Kurzrock R
    Ann Oncol; 2015 Aug; 26(8):1791-8. PubMed ID: 25908602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 37. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.
    Fang J; Cai C; Wang Q; Lin P; Zhao Z; Cheng F
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):177-187. PubMed ID: 28294568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
    Andre F; Vicier C; Delaloge S
    Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of Radiotherapy Trials Compared With Other Oncological Clinical Trials in the Past 10 Years.
    Liu X; Zhang Y; Tang LL; Le QT; Chua MLK; Wee JTS; Lee NY; O'Sullivan B; Lee AWM; Sun Y; Ma J
    JAMA Oncol; 2018 Aug; 4(8):1073-1079. PubMed ID: 29799987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.